Polymorphisms in the interleukin‐1 receptor antagonist and interleukin‐6 genes affect risk of osteolysis in patients with total hip arthroplasty
Open Access
- 29 September 2008
- journal article
- orthopedics
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (10), 3157-3165
- https://doi.org/10.1002/art.23863
Abstract
Objective To determine whether osteolysis after total hip arthroplasty (THA) is associated with common polymorphisms within the genes encoding the interleukin‐1 (IL‐1) family and IL‐6, and to determine whether polymorphisms that are associated with osteolysis affect in vitro messenger RNA (mRNA) expression in human peripheral blood mononuclear cells (PBMCs) in response to wear particles. Methods Unrelated white subjects of North European descent (n = 612) were recruited a mean of 11 years after cemented THA for primary osteoarthritis. Of these subjects, 272 had previous osteolysis and 340 had no radiographic evidence of osteolysis (control group). Genomic DNA was genotyped for the following single‐nucleotide polymorphisms (SNPs): IL1A +4845, IL1B +3954, IL1B –3737, IL1B –511, IL1RA +2018, IL6 –174, IL6 –572, and IL6 –597. In a subset of 60 subjects, PBMCs were extracted and stimulated with titanium particles and/or endotoxin, and cytokine mRNA expression was measured using quantitative real‐time reverse transcriptase–polymerase chain reaction. Results The odds ratio (OR) for osteolysis associated with carriage of the IL1RA +2018C allele was 0.66 (95% confidence interval [95% CI] 0.48–0.91) (P = 0.012). The remaining SNPs were not individually associated with osteolysis. The uncommon IL6 haplotype −174G/−572G/−597A (osteolysis group frequency 2.4%, control group frequency 0.8%) was associated with osteolysis (P = 0.02, calculated using Haploview software). The IL1RA +2018CC genotype was associated with increased mRNA expression compared with the +2018TT genotype in both unstimulated and stimulated PBMCs (P = 0.01 by analysis of variance, after Bonferroni correction). Conclusion The IL1RA +2018C allele is associated with a decreased risk of osteolysis after THA and with increased IL‐1 receptor antagonist mRNA expression in vitro. An uncommon haplotype within the promoter region of the gene for IL‐6 is positively associated with osteolysis.Keywords
This publication has 45 references indexed in Scilit:
- Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levelsGenes & Immunity, 2007
- Comparison of CT, MRI, and Radiographs in Assessing Pelvic OsteolysisPublished by Ovid Technologies (Wolters Kluwer Health) ,2005
- Association of the G-174C Variant in the Interleukin-6 Promoter Region With Bone Loss and Fracture Risk in Older WomenJournal of Bone and Mineral Research, 2004
- Variation in the TNF Gene Promoter and Risk of Osteolysis After Total Hip ArthroplastyJournal of Bone and Mineral Research, 2003
- Interleukin-1 Receptor Antagonist Gene Polymorphisms in Carotid AtherosclerosisStroke, 2003
- Genetic analysis of the interleukin‐1 receptor antagonist and its homologue IL‐1L1 in alopecia areata: strong severity association and possible gene interaction‡European Journal of Immunogenetics, 2002
- CYTOKINES AND OSTEOLYSIS AROUND TOTAL HIP PROSTHESESCytokine, 2000
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- A Clinical-Pathologic-Biochemical Study of the Membrane Surrounding Loosened and Nonloosened Total Hip ArthroplastiesClinical Orthopaedics and Related Research, 1989
- An interleukin 1 like factor stimulates bone resorption in vitroNature, 1983